4//SEC Filing
Rubin Eyal 4
Accession 0001104659-20-094755
CIK 0001006281other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 5:03 PM ET
Size
5.7 KB
Accession
0001104659-20-094755
Insider Transaction Report
Form 4
Rubin Eyal
Sr. VP & CFO
Transactions
- Award
Common Stock
2020-08-11+246,146→ 246,146 total(indirect: By Trust)
Footnotes (2)
- [F1]Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended June 7, 2020 (the "Plan"). Of the shares, 27,855 shares vest on September 22, 2020. The remaining 218,291 of the shares vest. Notwithstanding the foregoing and subject to certain exceptions, the vesting period will accelerate immediately upon a Change in Control, as defined in the Plan.
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001721411
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 5:03 PM ET
- Size
- 5.7 KB